This month marks the 16th anniversary of Hepatitis Awareness Month in the United States. Viral hepatitis, particularly infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), is a major cause of morbidity and mortality. This issue of MMWR includes a report that focuses on a recent trend in HCV infection.
Read Article >
Better support for patients with drug and alcohol dependency could help reduce complications from hepatitis C virus (HCV) infection a new study published in the Medical Journal of Australia has found.
Read Article >
A report on a study presented at the European Association for the Study of the Liver conference.
Read Article >
Dr. Samuel Wheeler French Jr., MD, PhD, Assistant Professor of Pathology and Laboratory Medicine at UCLA and researcher at UCLA's Jonsson Comprehensive Cancer Center, is evaluating the effects of several flavonoids on hepatitis C viral infection.
Read Release >
Roche Diagnostics is cooperating with the Spanish Vall d’Hebron Institute of Research, the Networking Biomedical Research Centre in Liver and Digestive Diseases, and the software producer Advanced Biological Laboratories Therapy Edge Spain in a study designed to resolve the current limitations that prevent the individualization of anti-HBV and anti-HCV (hepatitis B and C) treatments.
Read Release >
A national study to determine the incidence of hepatitis B virus (HBV) infection nationwide estimates that 0.27% of the U.S. population has chronic hepatitis B, according to a report in the March 2010 issue of the Annals of Internal Medicine.
Read Article >
Kids in the U.S. these days are largely immune to the hepatitis B virus (HBV), but high-risk adults still have low vaccination rates, according to a new study.
Read Article >
Early diagnosis and treatment of hepatitis B cuts health care costs and decreases death rates among patients infected with the hepatitis B virus (HBV), according to a study by New York School of Medicine and University of Pennsylvania School of Medicine researchers.
Read Article >
The FDA has approved the OraQuick® HCV Rapid Antibody Test, a finger stick for Hepatitis C.
Read Article >
Sharing of blood glucose monitoring equipment in assisted-living facilities has resulted in at least 16 outbreaks of hepatitis B virus (HBV) infection in the United States since 2004 (1,2). On October 12, 2010, the North Carolina Division of Public Health (NCDPH) and the Wayne County Health Department were notified by a local hospital of four residents of a single assisted-living facility with suspected acute HBV infection.
Read Article >